| N = 205 | |
---|---|---|
Age (years) | 68.8 ± 9.9 (37–88) | |
Male (%) | 71.5 | |
BMI (kg/m2) | 25.7 ± 4.1 | |
Blood pressure (systolic/diastolic) (mmHg) | 133.6 ± 19.2/74.8 ± 11.6 | |
Cardiovascular risk factors ≥3 (%) | 79.2 | |
 Hypertension | 87.0 | |
 Dyslipidemia | 65.2 | |
 Cardiovascular disease | 42.0 | |
  Coronary artery disease | 39.6 | |
  ASO | 2.4 | |
  Cerebral infarction | 2.9 | |
 Senior (≥65 years) | 73.4 | |
 Current smoking | 16.6 | |
 Obesity (BMI ≥25) | 52.9 | |
 Hyperuricemia (≥7.0 mg/dL) | 19.9 | |
Combination of oral hypoglycemic drugs (%) | Pre- | Post- |
 None | 52.6 | 56.3 |
 Sulfonylurea | 21.3 | 19.4 |
 α-Glucosidase inhibitor | 17.9 | 16.5 |
 Thiazolidinedione | 14.5 | 12.6 |
 Biguanide | 10.6 | 10.6 |
 Glinide | 6.3 | 2.4 |
ACEI/ARB | 63.6 | |
Calcium channel blocker | 41.5 | |
Statin | 58.3 |